Q1 FY27 results: Zero revenue, loss narrows to Rs 5.88 lakh

Cresanto Global Ltd (formerly Raymed Labs) reported Q1 FY27 results for quarter ended June 30, 2026. Revenue from operations stood at nil, versus nil in Q1 FY26 and Rs 5.39 lakh for FY26 full year. Total expenses were Rs 5.88 lakh, lower than Rs 9.21 lakh last year, mainly employee costs and other expenses. Net loss narrowed to Rs 5.88 lakh from Rs 9.21 lakh year-on-year and Rs 23.54 lakh in the previous quarter. Loss per share was Rs 0.14. Limited review report by KTPS and Co is clean. Board also approved shifting the corporate office within Goregaon East.